5,0
3 dic 2024
Dipendente attuale, meno di un anno
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Mid size Biopharmaceutical company passionate about helping patients with rare life debilitating diseases. The personalized approach and the willingness of everyone to help is refreshing.
Svantaggi
Some growing pains with the success of their PBC drug.